Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/cvr/cvu053 http://scihub22266oqcxt.onion/10.1093/cvr/cvu053 C4030512!4030512!24639195     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cardiovasc+Res 2014 ; 102 (3): 407-17 Nephropedia Template TP {{tp|p=24639195|t=2014. Integrins ?v?5 and ?v?3 promote latent TGF-?1 activation by human cardiac fibroblast contraction |pdf=|usr=}}{{24639195}} gab.com Text Integrins v 5 and v 3 promote latent TGF- 1 activation by human cardiac fibroblast contraction JO: Cardiovasc Res http://www.kidney.de/pget.php?&tw=1&pmid=24639195 #FOAvip Aims: Pathological tissue remodelling by myofibroblast contraction is a hallmark of cardiac fibrosis. Myofibroblasts differentiate from cardiac fibroblasts under the action of transforming growth factor-?1 (TGF-?1), which is secreted into the extracellular matrix as a large latent complex. Integrin-mediated traction forces activate TGF-?1 by inducing a conformational change in the latent complex. The mesenchymal integrins ?v?5 and ?v?3 are expressed in the heart, but their role in the activation of TGF-?1 remains elusive. Here, we test whether targeting ?v?5 and ?v?3 integrins reduces latent TGF-?1 activation by cardiac fibroblasts with the goal to prevent the formation of ?-smooth muscle actin (?-SMA)-expressing cardiac myofibroblasts and their contribution to fibrosis. Methods and results: Using a porcine model of induced right ventricular fibrosis and pro-fibrotic culture conditions, we show that integrins ?v?5 and ?v?3 are up-regulated in myofibroblast-enriched fibrotic lesions and differentiated cultured human cardiac myofibroblasts. Both integrins autonomously contribute to latent TGF-?1 activation and myofibroblast differentiation, as demonstrated by function-blocking peptides and antibodies. Acute blocking of both integrins leads to significantly reduced TGF-?1 activation by cardiac fibroblast contraction and loss of ?-SMA expression, which is restored by adding active TGF-?1. Manipulating integrin protein levels in overexpression and shRNA experiments reveals that both integrins can compensate for each other with respect to TGF-?1 activation and induction of ?-SMA expression. Conclusions: Integrins ?v?5 and ?v?3 both control myofibroblast differentiation by activating latent TGF-?1. Pharmacological targeting of mesenchymal integrins is a possible strategy to selectively block TGF-?1 activation by cardiac myofibroblasts and progression of fibrosis in the heart. Twit Text FOAVip Integrins v 5 and v 3 promote latent TGF- 1 activation by human cardiac fibroblast contraction ????Cardiovasc Res http://www.kidney.de/pget.php?&tw=1&pmid=24639195 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24639195 #FOAvip English Wikipedia <ref>{{Cite pmid|24639195}}</ref> Integrins ?v?5 and ?v?3 promote latent TGF-?1 activation by human cardiac fibroblast contraction #MMPMID24639195 Sarrazy V; Koehler A; Chow ML; Zimina E; Li CX; Kato H; Caldarone CA; Hinz B Cardiovasc Res 2014[Jun]; 102 (3): 407-17 PMID24639195show ga Aims: Pathological tissue remodelling by myofibroblast contraction is a hallmark of cardiac fibrosis. Myofibroblasts differentiate from cardiac fibroblasts under the action of transforming growth factor-?1 (TGF-?1), which is secreted into the extracellular matrix as a large latent complex. Integrin-mediated traction forces activate TGF-?1 by inducing a conformational change in the latent complex. The mesenchymal integrins ?v?5 and ?v?3 are expressed in the heart, but their role in the activation of TGF-?1 remains elusive. Here, we test whether targeting ?v?5 and ?v?3 integrins reduces latent TGF-?1 activation by cardiac fibroblasts with the goal to prevent the formation of ?-smooth muscle actin (?-SMA)-expressing cardiac myofibroblasts and their contribution to fibrosis. Methods and results: Using a porcine model of induced right ventricular fibrosis and pro-fibrotic culture conditions, we show that integrins ?v?5 and ?v?3 are up-regulated in myofibroblast-enriched fibrotic lesions and differentiated cultured human cardiac myofibroblasts. Both integrins autonomously contribute to latent TGF-?1 activation and myofibroblast differentiation, as demonstrated by function-blocking peptides and antibodies. Acute blocking of both integrins leads to significantly reduced TGF-?1 activation by cardiac fibroblast contraction and loss of ?-SMA expression, which is restored by adding active TGF-?1. Manipulating integrin protein levels in overexpression and shRNA experiments reveals that both integrins can compensate for each other with respect to TGF-?1 activation and induction of ?-SMA expression. Conclusions: Integrins ?v?5 and ?v?3 both control myofibroblast differentiation by activating latent TGF-?1. Pharmacological targeting of mesenchymal integrins is a possible strategy to selectively block TGF-?1 activation by cardiac myofibroblasts and progression of fibrosis in the heart. äIntegrins ?v?5 and ?v?3 promote latent TGF-?1 activation by human card(epmc).pdf DeepDyve Pubget Overpricing